M. Lucia

Role of Lymphocyte Multidrug Resistance Protein 1 in HIV Infection: Expression, Function, and Consequences of Inhibition

P. Matarrese, S. Rutella, W. Malorni, 2005, Journal of acquired immune deficiency syndromes.

Differential induction of P-glycoprotein and MRP by rifamycins in T lymphocytes from HIV-1/tuberculosis co-infected patients.

S. Rutella, G. Leone, R. Cauda, 2002, AIDS.

Atazanavir inhibits P-glycoprotein and multidrug resistance-associated protein efflux activity.

S. Rutella, R. Cauda, A. Savarino, 2005, Journal of acquired immune deficiency syndromes.

Flow cytometric detection of perforin in normal human lymphocyte subpopulations defined by expression of activation/differentiation antigens.

S. Rutella, G. Leone, R. Cauda, 1998, Immunology letters.

Anti-HIV Effects of Chloroquine: Inhibition of Viral Particle Glycosylation and Synergism With Protease Inhibitors

Sergio Rutella, Enrica Tamburrini, Roberto Cauda, 2004, Journal of acquired immune deficiency syndromes.

HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.

S. Rutella, G. Leone, S. Vella, 2001 .

RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies

R. de Caterina, W. Ageno, M. Vinceti, 2020, Vascular Pharmacology.

COVID-19 and intestinal inflammation: Role of fecal calprotectin

A. Gasbarrini, M. Consalvo, M. Pompili, 2020, Digestive and Liver Disease.